The use of L-arginine and sodium bicarbonate in the treatment of malabsorption due to cystic fibrosis.
D000293:Adolescent; D000328:Adult; D001120:Arginine / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D001835:Body Weight; D002338:Carotenoids / Q000032:analysis; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications*; D004386:Duodenum; D005223:Fats / Q000032:analysis; D005243:Feces / Q000032:analysis; D006801:Humans; D007419:Intestinal Secretions / Q000032:analysis; D008286:Malabsorption Syndromes / Q000188:drug therapy* / Q000209:etiology; D009584:Nitrogen / Q000032:analysis; D010184:Pancreatic Extracts / Q000627:therapeutic use; D010447:Peptide Hydrolases / Q000032:analysis; D012964:Sodium / Q000627:therapeutic use
D001639:Bicarbonates; D005223:Fats; D010184:Pancreatic Extracts; D002338:Carotenoids; D001120:Arginine; D012964:Sodium; D010447:Peptide Hydrolases; D009584:Nitrogen